ClinicalTrials.gg
Sign In

Sarcoma clinical trials

The registry lists 1,607 studies for Sarcoma across more than 10 countries. 366 are recruiting or about to start. 795 of them are mainly about Sarcoma (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 22 narrower conditions too, such as Osteosarcoma: 2,546 studies, 611 open.

ClinicalTrials.gov finds 3,090 studies for Sarcoma. How that becomes 1,607 here

This page counts the studies the registry files under Sarcoma, and those it files under no condition that list Sarcomathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 3,090Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −876Filed under a narrower condition, counted on its own pageOsteosarcoma 278 · Sarcoma, Kaposi 122 · Sarcoma, Ewing 87 · Rhabdomyosarcoma 55 · Leiomyosarcoma 51 · Liposarcoma 36 · 16 more
  3. −186List Sarcoma as a condition, but the registry did not file them under itMost often written as “Uterine Sarcoma” (14), “Retroperitoneal Sarcoma” (12), and “Ovarian Sarcoma” (11). The registry filed 77 of them under no condition at all, and the others under other conditions only, most often Uterine Cervical Neoplasms (15) and Endometrial Neoplasms (15).
  4. −421Match it another way72 name it in the title, 54 in a keyword, and 295 by a synonym or other text the search reads.
  5. 1,607The count on this page

Get an email when these change. Save the Sarcoma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
747
Recruiting
301
Terminated
181
Active, not recruiting
124
Status unknown
111
Withdrawn
62

Phase

Phase 2
709
Phase 1
490
Phase 3
86
Early Phase 1
37
Phase 4
9

Where

United States
958
France
175
Canada
145
China
133
United Kingdom
116
Germany
101

Who runs them

National Cancer Institute (NCI) (115) · Memorial Sloan Kettering Cancer Center (64) · M.D. Anderson Cancer Center (47) · Children's Oncology Group (44) · European Organisation for Research and Treatment of Cancer - EORTC (22) · Institut Bergonié (22) · Washington University School of Medicine (19) · Dana-Farber Cancer Institute (19)

What is being tested here

Drugs under test in Sarcoma studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Doxorubicin131265
Trabectedin6528
Pembrolizumab6020
Nivolumab6119
Anlotinib5218
Ifosfamide41246
Pazopanib4229
Atezolizumab408
Oncolytic HSV-1 R130405
Tetrachloroethane405

Drug classes tested here Immune checkpoint inhibitors 34 open · Tyrosine kinase inhibitors (TKIs) 26 open · Alkylating agents 9 open · Antimetabolites 5 open · Antimitotic agents 3 open

Coming up

17phase 3 studies under way
134studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 301 Sarcoma studies recruiting now, 191 (63%) set no upper age limit and 83 (28%) stop at 75 or younger. 91 (30%) take children under 18. 4 (1%) are for women only and 0 (0%) for men only; 12 (4%) take healthy volunteers.

Recruiting studies that take each age, of 301
AgeWomenMen
1060 (20%)60 (20%)
18288 (96%)284 (94%)
30279 (93%)275 (91%)
40266 (88%)263 (87%)
50256 (85%)254 (84%)
65257 (85%)255 (85%)
75239 (79%)237 (79%)
85211 (70%)210 (70%)

Across all 1,607 studies, recruiting or not: 27% stop at 75 or younger and 19% at 65; 36% take children; 2% are for women only and <1% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Sarcoma studies take

Of 227 phase 2 interventional studies under Sarcoma, half reached primary completion within 66 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 156 mo35–72 · 161 studies52 mo36–66 · 72 studies62 mo34–77 · 89 studies
Phase 1/262 mo45–106 · 101 studies59 mo43–89 · 44 studies71 mo51–117 · 57 studies
Phase 266 mo43–92 · 227 studies—66 mo46–91 · 198 studies
Phase 3105 mo50–155 · 24 studies——
Interventional, no phase59 mo34–120 · 147 studies—61 mo34–120 · 144 studies
Observational66 mo42–294 · 97 studies—72 mo42–294 · 88 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting2

Results posted4

Stopped5

Newly registered7

Show 2 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,607. Browse all 1,607 → or search them.